Every Form 4 that Edgewell Personal Care Company (EPC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow EPC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full EPC filings page.
Edgewell Personal Care Co. director Sit Swan reported an equity grant. On February 5, 2026, the director was awarded 7,817 restricted stock equivalents at a price of $0 per unit, held directly.
These restricted stock equivalents convert into shares of Edgewell common stock on the day before the next annual shareholder meeting, unless the director elects to defer conversion until service on the Board ends.
Edgewell Personal Care Company director Rakesh Sachdev reported an equity award in the form of derivative securities. On February 5, 2026, he received 7,817 restricted stock equivalents at a price of $0 per unit, all held as a direct ownership position.
According to the filing, these restricted stock equivalents are designed to convert into the same number of shares of Edgewell common stock on the day preceding the next annual meeting of shareholders, unless Sachdev elects to defer conversion until his service on the Board of Directors ends. After this transaction, he beneficially owns 7,817 derivative securities tied to Edgewell common stock.
Edgewell Personal Care director Stephanie Stahl reported a new equity grant. On February 5, 2026, she acquired 7,817 restricted stock equivalents at a price of $0 per unit. These are derivative securities that track the value of Edgewell common stock.
The restricted stock equivalents convert into shares of Edgewell common stock on the day before the next annual meeting of shareholders, unless Stahl elects to defer conversion until her service on Edgewell’s Board of Directors ends. After this grant, she beneficially owned 7,817 derivative units directly.
Edgewell Personal Care Company director receives equity grant. Director John C. Hunter III was granted 7,817 restricted stock equivalents of Edgewell common stock at a price of $0 on 02/05/2026. These restricted stock equivalents convert into common shares on the day before the next annual shareholder meeting, unless he elects to defer conversion until his service on the Board ends.
Edgewell Personal Care Company director Corbin George reported receiving 7,817 restricted stock equivalents on February 5, 2026. These derivative securities were acquired at a price of $0 and are held as direct ownership.
According to the filing, the restricted stock equivalents convert into shares of Edgewell common stock on the day before the next annual meeting of shareholders, unless the director elects to defer conversion until service on the Board ends.
Edgewell Personal Care Company director equity grant
Edgewell Personal Care Company reported that director Gary Waring received an award of 7,817 restricted stock equivalents on February 5, 2026. These derivative securities were granted at a price of $0 per unit and are held in his direct ownership.
The restricted stock equivalents convert into shares of Edgewell common stock on the day preceding the next annual meeting of shareholders, unless Waring elects to defer conversion until his service on Edgewell’s Board of Directors ends. After this grant, he beneficially owns 7,817 restricted stock equivalents.
Edgewell Personal Care director Carla C. Hendra received 7,817 restricted stock equivalents on February 5, 2026. These derivative awards carry a stated price of $0 per unit and are held directly. They are designed to convert into shares of Edgewell common stock on a future date.
The restricted stock equivalents convert into common shares on the day before the next annual shareholder meeting, unless the director chooses to defer conversion until service on the Board of Directors ends. After this grant, 7,817 derivative securities are beneficially owned.
Edgewell Personal Care Company director receives equity award. Director Robert William Black was granted 7,817 restricted stock equivalents on February 5, 2026 at a price of $0 per unit. Following this grant, he beneficially owns 7,817 derivative securities directly.
The restricted stock equivalents convert into shares of Edgewell common stock on the day before the next annual shareholder meeting, unless Black elects to defer conversion until his Board service ends.
Edgewell Personal Care (EPC) CFO reports stock transactions. On 12/02/2025, the CFO exercised 2,296 restricted stock equivalents at an exercise price of $0, receiving 2,296 shares of EPC common stock. On the same date, 798 shares were withheld and disposed of at $17 per share to cover tax liabilities related to the vesting. After these transactions, the CFO directly beneficially owned 29,034 shares of EPC common stock, and 4,590 restricted stock equivalents remained beneficially owned.
Edgewell Personal Care Company (EPC) reported an insider stock transaction by its Chief Accounting Officer. The officer sold 333 shares of Edgewell Personal Care common stock on 11/20/2025 at a price of $17.21 per share, as shown in Table I of the filing. After this sale, the reporting person disclosed owning 0 shares of Edgewell Personal Care common stock directly.
Edgewell Personal Care Company (EPC) Chief Supply Chain Officer reported multiple equity award events. On November 13, 2025, 5,773 Performance Stock Equivalents (PSEs) converted into the same number of EPC common shares after performance conditions were met, while 10,580 PSEs were canceled for not meeting those conditions. Shares totaling 2,676 and 1,924 were withheld at $18.39 per share to cover tax liabilities on vesting. A separate award of 4,149 PSEs had its performance conditions satisfied on November 6, 2025 and time vesting completed on November 13, 2025. In addition, the officer received 15,445 Restricted Stock Equivalents (RSEs) on November 14, 2025, each convertible into one share of EPC common stock, vesting in three equal annual installments. Following these transactions, the officer beneficially owned about 48,564.693 shares of EPC common stock directly.
Edgewell Personal Care (EPC) reported insider equity transactions by Chief Executive Officer and Director Rod R. Little. On 11/13/2025, 58,612 performance stock equivalents vested and converted into shares of common stock at an exercise price of $0. On the same date, 27,167 shares were withheld to cover tax liabilities at a price of $18.39 per share, leaving Little with 365,818 shares of common stock held directly.
In a related derivative transaction, the original performance award was 166,038 shares, of which only 58,612 vested based on performance criteria, with 107,426 shares cancelled. On 11/14/2025, Little received a grant of 103,420 restricted stock equivalents at an exercise price of $0. One-third of this award will vest and convert into Edgewell common stock on each of 11/14/2026, 11/14/2027, and 11/14/2028, subject to continued employment or certain other events.
Edgewell Personal Care Company (EPC) reported insider equity transactions by its Chief People & Legal Officer on 11/13/2025. A performance stock award vested, converting 5,773 performance stock equivalents into common shares at an exercise price of $0, increasing the officer’s direct holdings to 22,540 shares before related tax withholding. To cover tax liabilities on the vesting, 2,873 shares were withheld at a price of $18.39, leaving 19,667 common shares held directly afterward.
In a related equity grant dated 11/14/2025, the officer received 24,270 restricted stock equivalents at an exercise price of $0. These are scheduled to vest in three equal installments on 11/14/2026, 11/14/2027, and 11/14/2028, subject to continued employment, with potential accelerated vesting upon death, disability, change in control, or certain termination events. The original performance award was for 16,353 units, of which 10,580 were cancelled for not meeting performance criteria.
Edgewell Personal Care (EPC) reported insider equity activity by its CFO on a Form 4. On 11/13/2025, 2,754 performance stock equivalents were exercised at $0 and converted into common stock, while 958 shares were withheld at $18.39 to cover tax liabilities. Following these transactions, the CFO directly held 27,536 shares of common stock. In a related derivative transaction, the original performance award was 3,900 shares, of which 2,754 vested and 1,146 were cancelled based on performance criteria. On 11/14/2025, the CFO also received 26,476 restricted stock equivalents, scheduled to vest in three equal installments on 11/14/2026, 11/14/2027, and 11/14/2028, subject to continued employment or certain other events.
Edgewell Personal Care Company reported an equity award to one of its officers on Form 4. The reporting person, who serves as President, North America, received 26,476 restricted stock equivalents (RSEs) tied to Edgewell common stock on 11/14/2025 at an exercise price of $0.
According to the vesting terms, one-third of these RSEs will convert into shares of Edgewell common stock on each of 11/14/2026, 11/14/2027 and 11/14/2028, as long as the officer remains employed on those dates. All or a portion of the RSEs may vest earlier upon death, disability, a change in control, or certain termination events.
Edgewell Personal Care Co. (EPC) reported an equity award to its Chief Accounting Officer, John M. Dunham, in a Form 4 filing. On 11/14/2025, he received 3,586 restricted stock equivalents at a price of $0 per unit. These awards are scheduled to vest in three equal installments on 11/14/2026, 11/14/2027, and 11/14/2028, converting into shares of Edgewell common stock as they vest. Vesting requires continued employment on each vesting date, although all or a portion may vest earlier in cases such as death, disability, change in control, or certain termination events.
Edgewell Personal Care (EPC) reported insider transactions by its Chief Supply Chain Officer reflecting RSU vesting and tax withholding over three days. On 11/08/2025, 4,425 shares were acquired at $0 via the conversion of restricted stock equivalents, with 2,051 shares withheld for taxes at $18.83. On 11/10/2025, 2,046 shares were acquired at $0 and 949 shares were withheld at $18.83. On 11/11/2025, 1,635 shares were acquired at $0 and 758 shares were withheld at $18.57.
Following these transactions, direct ownership stood at 43,242.693 shares. The filing notes these were conversions of restricted stock equivalents and that shares were withheld to cover tax liabilities upon vesting.
Edgewell Personal Care (EPC): Chief People & Legal Officer LaTanya Langley reported routine equity award activity. Restricted stock equivalents vested and converted into common stock on three dates: 3,688 shares on 11/08/2025, 2,338 shares on 11/10/2025, and 1,635 shares on 11/11/2025, each at an exercise price of $0.
To cover taxes upon vesting, shares were withheld: 1,835 at $18.83 on 11/08/2025, 1,164 at $18.83 on 11/10/2025, and 814 at $18.57 on 11/11/2025. Following these transactions, the officer directly owned 16,767 shares.
Edgewell Personal Care (EPC) reported an insider transaction by its Chief Accounting Officer. On 11/08/2025, 461 shares of common stock were acquired at $0 upon the vesting and conversion of restricted stock equivalents (code M). To cover taxes, 128 shares were withheld at $18.83 (code F).
Following these transactions, the officer directly owns 333 shares of EPC common stock. Derivative holdings consist of 922 restricted stock equivalents after the reported activity.
Edgewell Personal Care (EPC) CEO and director Rod R. Little reported multiple equity transactions. On 11/08/2025, 11/10/2025, and 11/11/2025, restricted stock equivalents vested and converted to common stock (codes M) for 17,285, 14,612, and 12,578 shares at $0, respectively.
To cover taxes on these vestings (code F), shares were withheld: 8,012 at $18.83 on 11/08/2025, 6,773 at $18.83 on 11/10/2025, and 5,830 at $18.57 on 11/11/2025. Following these transactions, Mr. Little beneficially owned 334,373 shares directly.
Edgewell Personal Care (EPC) CFO reported routine equity transactions on Form 4 tied to restricted stock equivalents vesting. On 11/10/2025, 1,023 shares of common stock were acquired at $0 upon vesting, followed by 356 shares withheld at $18.83 to cover taxes. On 11/11/2025, an additional 780 shares vested at $0, with 272 shares withheld at $18.57 for taxes.
Following these transactions, the CFO directly holds 25,740 shares of EPC common stock. The filing labels the acquisitions as code “M” (conversion of derivative securities) and the withholdings as code “F” (tax withholding), consistent with standard equity award vesting mechanics.
Edgewell Personal Care (EPC): Form 4 insider activity
Officer Jessica Spence, President, North America, reported the vesting and conversion of 4,425 restricted stock equivalents into EPC common stock on 11/08/2025 (Code M) at an exercise price of $0. To satisfy tax obligations, 2,390 shares were withheld (Code F) at a price of $18.83.
Following these transactions, the reporting person directly owns 2,035 shares of EPC common stock. The filing also lists 8,850 derivative securities (restricted stock equivalents) beneficially owned after the reported activity.